# To Study Lower Dose of Cyclophosphamide After Stem Cell Transplant for Blood Cancers

> **NCT07719946** · PHASE2 · RECRUITING · sponsor: **Tata Memorial Centre** · enrollment: 20 (estimated)

## Conditions studied

- Haploidentical Hematopoietic Stem Cell Transplant
- Hematological Malignancies

## Interventions

- **DRUG:** Cyclophosphamide

## Key facts

- **NCT ID:** NCT07719946
- **Lead sponsor:** Tata Memorial Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-26
- **Primary completion:** 2028-11-12
- **Final completion:** 2028-11-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07719946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07719946, "To Study Lower Dose of Cyclophosphamide After Stem Cell Transplant for Blood Cancers". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07719946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*